Physician profile
Donald E Smith
NPI 1477621597
$6,277.35
in general payments reported to CMS, 2019-2025
37 companies · $1,383 in 2025
The $1,383 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,096 · 2022: $1,451 · 2023: $1,189 · 2024: $1,158 · 2025: $1,383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,730.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,242.97 | 2022-2025 | Caplyta |
| Abbvie INC. | $960.38 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $840.24 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $646.24 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $542.08 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $175.82 | 2022-2025 | |
| Pfizer INC. | $169.81 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $153.82 | 2021-2023 | Verquvo, Steglujan, Steglatro |
| Nestle Healthcare Nutrition INC. | $152.99 | 2021-2023 | |
| Amgen INC. | $150.38 | 2022-2025 | Evenity, Prolia, Prolia |
| Lilly USA, LLC | $128.49 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Exact Sciences Corporation | $120.60 | 2023-2025 | Cologuard Collection Kit |
| Eisai INC. | $87.76 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $81.93 | 2021-2024 | Eliquis |
| Aimmune Therapeutics, INC. | $77.43 | 2024-2025 | Zenpep |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $73.25 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.67 | 2021-2024 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $56.89 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $54.47 | 2021 | |
| Lundbeck LLC | $52.60 | 2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $41.88 | 2022 | |
| Axsome Therapeutics, INC. | $39.83 | 2022 | |
| Digestive Care, INC. | $39.48 | 2025 | Pertzye |
| Alkermes, INC. | $36.61 | 2021 | |
| Amarin Pharma, INC. | $35.05 | 2021 | |
| Medicure Pharma INC. | $26.71 | 2021 | |
| Idorsia Pharmaceuticals US INC | $25.00 | 2023 | Quviviq |
| Electromed, INC. | $23.83 | 2025 | Smartvest |
| Hologic Sales and Service, LLC | $22.91 | 2025 | Aptima |
| Daiichi Sankyo INC. | $21.88 | 2024 | Injectafer |
| Echosens North America, INC. | $19.98 | 2024 | Fibroscan |
| Medtronic, INC. | $19.96 | 2022 | |
| Allergan, INC. | $19.81 | 2021 | |
| Abbott Laboratories | $18.05 | 2025 | Freestyle Libre 3 |
| Radius Health, INC. | $17.64 | 2021 | |
| Astellas Pharma US INC | $17.56 | 2024 | Veozah |
| Janssen Pharmaceuticals, INC | $15.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.